Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 451

1.

HSD17B13 truncated variant is associated with a mild hepatic phenotype in Wilson's Disease.

Ferenci P, Pfeiffenberger J, Stättermayer AF, Stauber RE, Willheim C, Weiss KH, Munda-Steindl P, Trauner M, Schilsky M, Zoller H.

JHEP Rep. 2019 Mar 19;1(1):2-8. doi: 10.1016/j.jhepr.2019.02.007. eCollection 2019 May.

2.

Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension.

Scheiner B, Stättermayer AF, Schwabl P, Bucsics T, Paternostro R, Bauer D, Simbrunner B, Schmidt R, Marculescu R, Ferlitsch A, Peck-Radosavljevic M, Pinter M, Trauner M, Reiberger T, Ferenci P, Mandorfer M.

Liver Int. 2020 Feb;40(2):393-404. doi: 10.1111/liv.14304. Epub 2019 Dec 3.

3.

Hepatitis B virus RNA as Early Predictor for Response to PEGylated Interferon Alfa in HBeAg Negative Chronic Hepatitis B.

Farag MS, van Campenhout MJH, Pfefferkorn M, Fischer J, Deichsel D, Boonstra A, van Vuuren AJ, Ferenci P, Feld JJ, Berg T, Hansen BE, van Bömmel F, Janssen HLA.

Clin Infect Dis. 2020 Jan 8. pii: ciaa013. doi: 10.1093/cid/ciaa013. [Epub ahead of print]

PMID:
31912157
4.

Non-invasive diagnosis of cirrhosis and long-term disease monitoring by transient elastography in patients with Wilson disease.

Paternostro R, Pfeiffenberger J, Ferenci P, Stättermayer AF, Stauber RE, Wrba F, Longerich T, Lackner K, Trauner M, Ferlitsch A, Reiberger T, Weiss KH.

Liver Int. 2020 Jan 2. doi: 10.1111/liv.14368. [Epub ahead of print]

PMID:
31898387
5.

Are all cirrhotic patients equal?

Ferenci P.

J Hepatol. 2020 Mar;72(3):389-390. doi: 10.1016/j.jhep.2019.10.022. Epub 2019 Nov 6. No abstract available.

PMID:
31703944
6.

Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient.

Mandorfer M, Peck-Radosavljevic M, Ferenci P, Reiberger T.

Liver Int. 2019 Oct 15. doi: 10.1111/liv.14273. [Epub ahead of print] No abstract available.

PMID:
31612610
7.

Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy.

Mandorfer M, Kozbial K, Schwabl P, Chromy D, Semmler G, Stättermayer AF, Pinter M, Hernández-Gea V, Fritzer-Szekeres M, Steindl-Munda P, Trauner M, Peck-Radosavljevic M, García-Pagán JC, Ferenci P, Reiberger T.

Hepatology. 2020 Mar;71(3):1023-1036. doi: 10.1002/hep.30885. Epub 2019 Oct 14.

8.

Excellent safety and effectiveness of high-dose myrcludex-B monotherapy administered for 48 weeks in HDV-related compensated cirrhosis: A case report of 3 patients.

Loglio A, Ferenci P, Uceda Renteria SC, Tham CYL, van Bömmel F, Borghi M, Holzmann H, Perbellini R, Trombetta E, Giovanelli S, Greco L, Porretti L, Prati D, Ceriotti F, Lunghi G, Bertoletti A, Lampertico P.

J Hepatol. 2019 Oct;71(4):834-839. doi: 10.1016/j.jhep.2019.07.003. Epub 2019 Jul 11.

PMID:
31302176
9.

The dilemma to diagnose Wilson disease by genetic testing alone.

Stättermayer AF, Entenmann A, Gschwantler M, Zoller H, Hofer H, Ferenci P.

Eur J Clin Invest. 2019 Aug;49(8):e13147. doi: 10.1111/eci.13147. Epub 2019 Jun 20.

10.

Hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B.

van Campenhout MJH, Rijckborst V, Brouwer WP, van Oord GW, Ferenci P, Tabak F, Akdogan M, Pinarbasi B, Simon K, de Knegt RJ, Boonstra A, Janssen HLA, Hansen BE.

J Viral Hepat. 2019 Oct;26(10):1156-1163. doi: 10.1111/jvh.13117. Epub 2019 Aug 4.

PMID:
31135084
11.

Wilson's disease: Fatal when overlooked, curable when diagnosed.

Ferenci P, Ott P.

J Hepatol. 2019 Jul;71(1):222-224. doi: 10.1016/j.jhep.2019.02.002. Epub 2019 May 22. No abstract available.

PMID:
31126728
12.

Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication.

Chromy D, Mandorfer M, Bucsics T, Schwabl P, Bauer D, Scheiner B, Schmidbauer C, Lang GF, Szekeres T, Ferenci P, Trauner M, Reiberger T.

AIDS Patient Care STDS. 2019 May;33(5):197-206. doi: 10.1089/apc.2018.0333.

PMID:
31067123
13.

High efficacy of interferon-free therapy for acute hepatitis C in HIV-positive patients.

Chromy D, Mandorfer M, Bucsics T, Schwabl P, Scheiner B, Schmidbauer C, Aichelburg MC, Ferenci P, Trauner M, Peck-Radosavljevic M, Reiberger T.

United European Gastroenterol J. 2019 May;7(4):507-516. doi: 10.1177/2050640619835394. Epub 2019 Mar 6.

14.

Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.

Semmler G, Simbrunner B, Scheiner B, Schwabl P, Paternostro R, Bucsics T, Stättermayer AF, Bauer D, Pinter M, Ferenci P, Trauner M, Mandorfer M, Reiberger T.

J Gastroenterol Hepatol. 2019 Dec;34(12):2164-2172. doi: 10.1111/jgh.14700. Epub 2019 Jun 14.

15.

Real-world safety and effectiveness of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C virus genotype 1- and 4-infected patients with diverse comorbidities and comedications: A pooled analysis of post-marketing observational studies from 13 countries.

Ferenci P, Bourgeois S, Buggisch P, Norris S, Curescu M, Larrey D, Marra F, Kleine H, Dorr P, Charafeddine M, Crown E, Bondin M, Back D, Flisiak R.

J Viral Hepat. 2019 Jun;26(6):685-696. doi: 10.1111/jvh.13080. Epub 2019 Mar 5.

16.

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study.

Brouwer WP, Chan HLY, Lampertico P, Hou J, Tangkijvanich P, Reesink HW, Zhang W, Mangia A, Tanwandee T, Montalto G, Simon K, Ormeci N, Chen L, Tabak F, Gunsar F, Flisiak R, Ferenci P, Akdogan M, Akyuz F, Hirankarn N, Jansen L, Wong VW, Soffredini R, Liang X, Chen S, Groothuismink ZMA, Santoro R, Jaroszewicz J, Ozaras R, Kozbial K, Brahmania M, Xie Q, Chotiyaputta W, Xun Q, Pazgan-Simon M, Oztas E, Verhey E, Montanari NR, Sun J, Hansen BE, Boonstra A, Janssen HLA; GIANT-B Global Consortium .

Clin Infect Dis. 2019 Nov 13;69(11):1969-1979. doi: 10.1093/cid/ciz084.

17.

Hepatic manifestations of Wilson's disease: 12-year experience in a Swiss tertiary referral centre.

Vieira Barbosa J, Fraga M, Saldarriaga J, Hiroz P, Giostra E, Sempoux C, Ferenci P, Moradpour D.

Swiss Med Wkly. 2018 Dec 21;148:w14699. doi: 10.4414/smw.2018.14699. eCollection 2018 Dec 17.

18.

Quantitative trace element mapping in liver tissue from patients with Wilson`s disease determined by micro X-ray fluorescence.

Osterode W, Falkenberg G, Ferenci P, Wrba F.

J Trace Elem Med Biol. 2019 Jan;51:42-49. doi: 10.1016/j.jtemb.2018.09.007. Epub 2018 Sep 27.

PMID:
30466937
19.

Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease.

Ferenci P, Stremmel W, Członkowska A, Szalay F, Viveiros A, Stättermayer AF, Bruha R, Houwen R, Pop TL, Stauber R, Gschwantler M, Pfeiffenberger J, Yurdaydin C, Aigner E, Steindl-Munda P, Dienes HP, Zoller H, Weiss KH.

Hepatology. 2019 Apr;69(4):1464-1476. doi: 10.1002/hep.30280. Epub 2019 Mar 1.

PMID:
30232804
20.

Wilson disease.

Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML.

Nat Rev Dis Primers. 2018 Sep 6;4(1):21. doi: 10.1038/s41572-018-0018-3. Review.

Supplemental Content

Loading ...
Support Center